192 related articles for article (PubMed ID: 22644511)
1. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Kadota K; Colovos C; Suzuki K; Rizk NP; Dunphy MP; Zabor EC; Sima CS; Yoshizawa A; Travis WD; Rusch VW; Adusumilli PS
Ann Surg Oncol; 2012 Oct; 19(11):3598-605. PubMed ID: 22644511
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
[TBL] [Abstract][Full Text] [Related]
3. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
[TBL] [Abstract][Full Text] [Related]
4. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
5. Relationship between
Bu L; Tu N; Wang K; Zhou Y; Xie X; Han X; Lin H; Feng H
Korean J Radiol; 2022 Jan; 23(1):112-123. PubMed ID: 34983098
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of
Lococo F; Guerrera F; Rena O; Ampollini L; Vannucci J; Bertoglio P; Ventura L; Lyberis P; Marchese V; Arena V; Filosso PL; Lesca A; Casadio C; Viti A; Paci M; Puma F; Ruffini E
Heart Lung Circ; 2022 May; 31(5):726-732. PubMed ID: 34753661
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers.
Lee HY; Jeong JY; Lee KS; Yi CA; Kim BT; Kang H; Kwon OJ; Shim YM; Han J
J Magn Reson Imaging; 2013 Oct; 38(4):905-13. PubMed ID: 23908132
[TBL] [Abstract][Full Text] [Related]
9. [Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Liu Y; Wu N; Bi GC; Zhang DS; Zheng R; Liang Y; Zhang WJ; Li XM; Fang Y
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):263-9. PubMed ID: 27087372
[TBL] [Abstract][Full Text] [Related]
10. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
12. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
13. Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.
Nitadori J; Bograd AJ; Morales EA; Rizk NP; Dunphy MP; Sima CS; Rusch VW; Adusumilli PS
Ann Surg Oncol; 2013 Dec; 20(13):4282-8. PubMed ID: 23955584
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
[TBL] [Abstract][Full Text] [Related]
16. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.
Kadota K; Yeh YC; Sima CS; Rusch VW; Moreira AL; Adusumilli PS; Travis WD
Mod Pathol; 2014 May; 27(5):690-700. PubMed ID: 24186133
[TBL] [Abstract][Full Text] [Related]
17. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
[TBL] [Abstract][Full Text] [Related]
18. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
